VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
BRTX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
BRTXBioRestorative Therapies, Inc.
$0.37$3M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksBRTXQuarterly Financials

BioRestorative Therapies, Inc. (BRTX) Quarterly Financials

120+ quarters historyFree accessUpdated daily

BioRestorative Therapies, Inc. (BRTX) quarterly income statement — complete revenue, gross profit & net income history

BRTX Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue23.17K19.6K11.8K303.3K25K43.3K233.6K89.1K35K19.3K30.7K64.5K31.3K3.7K29K71.1K16K5K8K15K
Revenue Growth %-7.32%-54.73%-94.95%240.4%-28.57%124.35%660.91%38.14%11.82%421.62%5.86%-9.28%95.63%-26%262.5%374%-11.11%-70.59%-46.67%-21.05%
Cost of Goods Sold7.38K1.64K10.57K8.73K2.91K3.34K18.24K6.49K042.71K0000000000
COGS % of Revenue31.87%8.35%89.58%2.88%11.64%7.71%7.81%7.28%-221.31%----------
Gross Profit15.79K17.96K1.23K294.57K22.09K39.96K215.36K82.61K35K-23.41K30.7K64.5K31.3K3.7K29K71.1K16K5K8K15K
Gross Margin %68.13%91.65%10.42%97.12%88.36%92.29%92.19%92.72%100%-121.31%100%100%100%100%100%100%100%100%100%100%
Gross Profit Growth %-28.55%-55.05%-99.43%256.58%-36.88%270.68%601.49%28.08%11.82%-732.78%5.86%-9.28%95.63%-26%262.5%374%-11.11%-70.59%-46.67%-21.05%
Operating Expenses3.4M3.84M3.71M3.6M4.83M2.73M2.5M2.55M4.14M3.2M3.14M3.18M5.81M4.69M4.64M4.7M5.07M4.01M3.7M3.57M
OpEx % of Revenue14680.7%19608.49%31442.72%1186.9%19318.5%6305.09%1071.21%2863.54%11840.72%16566.16%10212.19%4931.86%18563.57%126637.95%15995.52%6610.03%31686.21%80285.34%46208.59%23801.75%
Selling, General & Admin1.48M1.22M1.12M1.37M3.12M1.07M1.18M1.26M3.09M2.52M2.33M2.28M4.58M4.01M3.65M3.62M4.29M3.85M3.46M3.41M
SG&A % of Revenue6366.88%6204.72%9453.31%453.01%12461.19%2475.49%506.13%1413.28%8817.49%13039.58%7574.33%3532.03%14628.28%108431.97%12584.59%5097.76%26840.35%76975.42%43240.96%22729.1%
Research & Development1.93M2.63M2.59M2.23M1.71M1.66M1.32M1.29M1.06M680.63K809.82K902.89K1.23M673.62K989.17K1.08M775.34K165.5K237.41K160.9K
R&D % of Revenue8313.82%13403.77%21989.41%733.89%6857.31%3829.59%565.08%1450.26%3023.23%3526.59%2637.86%1399.83%3935.29%18205.97%3410.93%1512.27%4845.86%3309.92%2967.63%1072.65%
Other Operating Expenses00000000000000000000
Operating Income-3.39M-3.83M-3.71M-3.31M-4.81M-2.69M-2.29M-2.47M-4.11M-3.22M-3.1M-3.12M-5.78M-4.68M-4.61M-4.63M-5.05M-4.01M-3.69M-3.56M
Operating Margin %-14612.57%-19516.84%-31432.3%-1089.77%-19230.14%-6212.8%-979.02%-2770.83%-11740.72%-16687.46%-10112.19%-4831.86%-18463.57%-126537.95%-15895.52%-6510.03%-31586.21%-80185.34%-46108.59%-23701.75%
Operating Income Growth %29.57%-42.2%-62.18%-33.88%-16.99%16.47%26.33%20.78%28.89%31.21%32.65%32.67%-14.35%-16.78%-24.97%-30.19%66.43%-369.21%-504.44%-670.22%
EBITDA-3.39M-3.77M-3.66M-3.25M-4.76M-2.64M-2.24M-2.42M-4.07M-3.18M-3.06M-3.08M-5.74M-4.58M-4.55M-4.6M-5M-3.96M-3.67M-3.53M
EBITDA Margin %-14612.57%-19247.27%-30986.36%-1072.38%-19023.01%-6096.47%-958.36%-2717.29%-11618.68%-16466.15%-9974.91%-4767.48%-18337.85%-123703.3%-15687.81%-6465.7%-31242.32%-79174.14%-45838.88%-23556.19%
EBITDA Growth %28.81%-42.91%-63.32%-34.34%-16.95%16.94%26.89%21.27%29.15%30.57%32.69%33.11%-14.82%-15.62%-24.06%-30.1%66.74%-377.53%-527.07%-712.46%
D&A (Non-Cash Add-back)052.84K52.62K52.75K51.78K50.37K48.27K47.7K42.71K42.71K42.15K41.53K39.35K104.88K60.24K31.52K55.02K50.56K21.58K21.83K
EBIT-3.39M-3.83M-3.71M-2.66M-4.81M-2.69M-2.29M-2.47M-4.11M-3.22M-3.02M-5.71M-7.17M-4.35M-4.63M-4.63M-4.79M-20.19M-3.69M-3.56M
Net Interest Income034.59K57.74K73.92K99.97K118.99K158.55K175.94K162.6K200.15K61.67K96.19K18.22K116.11K-28.84K-46.61K-29.01K-213.81K-495.55K-507.33K
Interest Income034.59K57.74K73.92K99.97K118.99K158.55K175.94K162.6K376.22K61.67K96.19K18.22K116.11K000000
Interest Expense000000000176.07K000028.84K46.61K29.01K213.81K495.55K507.33K
Other Income/Expense1.23M617.66K670.73K649.02K-532.26K1.05M1.2M-1.56M1.89M4.39M7.87M-2.59M-1.39M334.35K-46.13K-46.61K237.64K-16.39M-495.54K-507.33K
Pretax Income-2.15M-3.21M-3.04M-2.66M-5.34M-1.64M-1.09M-4.03M-2.22M1.17M4.77M-5.71M-7.17M-4.35M-4.66M-4.68M-4.82M-20.4M-4.18M-4.06M
Pretax Margin %-9298.25%-16365.49%-25748.11%-875.79%-21359.2%-3778.63%-467.22%-4521.39%-6352.16%6075.45%15531.79%-8851.78%-22915.57%-117501.43%-16054.57%-6575.59%-30100.94%-408062.76%-52302.89%-27083.97%
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-2.15M-3.21M-3.04M-2.66M-5.34M-1.64M-1.09M-4.03M-2.22M1.17M4.77M-5.71M-7.17M-4.35M-4.66M-4.68M-4.82M-20.4M-4.18M-4.06M
Net Margin %-9298.25%-16365.49%-25748.11%-875.79%-21359.2%-3778.63%-467.22%-4521.39%-6352.16%6075.45%15531.79%-8851.78%-22915.57%-117501.43%-16054.57%-6575.59%-30100.94%-408062.76%-52302.89%-27083.97%
Net Income Growth %59.65%-96.05%-178.38%34.06%-140.18%-239.54%-122.89%29.44%69%126.97%202.42%-22.12%-48.93%78.69%-11.27%-15.08%69.23%-254.14%-400.35%-241.28%
Net Income (Continuing)-2.15M-3.21M-3.04M-2.66M-5.34M-1.64M-1.09M-4.03M-2.22M1.17M4.77M-5.71M-7.17M-4.35M-4.66M-4.68M-4.82M-20.4M-4.18M-4.06M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.24-0.36-0.33-0.30-0.64-0.21-0.13-0.50-0.330.251.04-1.47-1.93-1.19-1.28-1.28-1.37-23.39-4.80-4.85
EPS Growth %62.5%-71.43%-153.85%40%-93.94%-184%-112.5%65.99%82.9%121.01%181.25%-14.84%-40.88%94.91%73.33%73.61%93.05%-222.18%-128.57%-167.27%
EPS (Basic)-0.24-0.36-0.33-0.30-0.64-0.21-0.13-0.50-0.330.251.04-1.47-1.93-1.19-1.28-1.28-1.37-23.39-4.99-5.10
Diluted Shares Outstanding8.99M8.88M9.12M8.74M8.36M7.76M8.12M8.12M6.67M4.71M4.57M3.89M3.72M3.67M3.64M3.64M3.52M872.21K872.21K836.94K
Basic Shares Outstanding8.99M8.88M9.12M8.74M8.36M7.76M8.12M8.12M6.67M4.71M4.57M3.89M3.72M3.67M3.64M3.64M3.52M872.21K838.69K795.88K
Dividend Payout Ratio--------------------